493
Participants
Start Date
December 31, 2011
Primary Completion Date
March 19, 2017
Study Completion Date
April 18, 2017
Metformin
3 years treatment duration
Placebo
3 years duration
Royal Melbourne Hospital, Melbourne
St Vincent's Hospital, Melbourne
Royal Prince Albert Hospital, Sydney
St Joseph's Health Care, London
Ottawa Hospital Riverside Campus, Ottawa
Steno Diabetes Centre, Gentofte Municipality
Maastricht University Medical Centre, Maastricht
Aberdeen Royal Infirmary, Aberdeen
Diabetes Support Unit, Ninewells Hospital and Medical School, Dundee
University Hospital North Durham, Durham
Edinburgh Royal Infirmary, Edinburgh
Edinburgh Western Infirmary, Edinburgh
Peninsula NIHR Clinical Research Facility, Royal Devon and Exeter NHS Foundation Trust, Exeter
Stobhill Hospital, Diabetes Clinic, Glasgow
Michael White Diabetes Centre, Hull Royal Infirmary, Hull
Clinical Sciences Centre, University Hospital, Liverpool
Clinical Investigation Unit, International Centre for Circulatory Health, Imperial College Healthcare NHS Trust, London
Wellcome Trust Clinical Research Facility, Manchester Royal Infirmary, Manchester
Newcastle NIHR Clinical Research Facility, Royal Victoria Hospital, Newcastle
Diabetes Clinical Research Centre, Plymouth, Plymouth
Salford Royal NHS Foundation Trust, Salford
Ayr Hospital, Ayr
University Hospitals Bristol, Bristol
Gloucestershire Royal Hospital, Gloucester
Collaborators (2)
NHS Greater Glasgow and Clyde
OTHER
Juvenile Diabetes Research Foundation
OTHER
Imperial College London
OTHER
University of Wisconsin, Madison
OTHER
University of Dundee
OTHER
Merck Serono S.A., Geneva
INDUSTRY
Itamar-Medical, Israel
INDUSTRY
University of Western Ontario, Canada
OTHER
University of Melbourne
OTHER
Steno Diabetes Center Copenhagen
OTHER
Maastricht University Medical Center
OTHER
University of Glasgow
OTHER